MedTrace Logo

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A

NCT04181697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-11-30

No results posted yet for this study

Summary

The study aims to describe physical activity (PA) levels in young people with haemophilia A in Norway compared with non-haemophilia controls, and to identify factors influencing PA. This will be conducted through an observational study measuring PA over 12 weeks. Forty young people with moderate and severe haemophilia A will be enrolled. PA data will be compared to demographically and seasonally matched non-haemophilia controls. PA will be measured using the activity tracker Fitbit Charge 3. A subgroup of participants will also wear the hip-worn accelerometer ActiGraph GTX+BT for seven consecutive days in order to validate the two devices against each other.

Conditions

  • Hemophilia A Without Inhibitor

Interventions

DEVICE

PA measurement with Fitbit Charge 3

Measurement of PA with Fitbit for all participants and controls.

DEVICE

PA measurement with Fitbit and ActiGraph GT3X

Measurement of PA with ActiGraph for a subgroup of 20 participants.

Sponsors & Collaborators

  • Norwegian School of Sport Sciences

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Eligibility

Min Age
13 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-05
Primary Completion
2020-08-27
Completion
2020-08-27

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181697 on ClinicalTrials.gov